Dodecyltrimethylammonium (bromide) |
A quaternary ammonium-containing cationic surfactant; CMC = 15.7 and 8.1 m… |
5 g |
37009-5 |
More Info
|
Dodecyltrimethylammonium (bromide) |
A quaternary ammonium-containing cationic surfactant; CMC = 15.7 and 8.1 m… |
50 g |
37009-50 |
More Info
|
DOET |
A potent, long-acting psychedelic drug of the phenethylamine and amphetami… |
10 mg |
11141-10 |
More Info
|
DOET |
A potent, long-acting psychedelic drug of the phenethylamine and amphetami… |
5 mg |
11141-5 |
More Info
|
DOET |
A potent, long-acting psychedelic drug of the phenethylamine and amphetami… |
50 mg |
11141-50 |
More Info
|
DOET (exempt preparation) |
A potent, long-acting psychedelic drug of the phenethylamine and amphetami… |
1 mg |
15704-1 |
More Info
|
Dofequidar |
A quinoline derivative and inhibitor of multidrug resistance; inhibits P-g… |
1 mg |
30925-1 |
More Info
|
Dofequidar |
A quinoline derivative and inhibitor of multidrug resistance; inhibits P-g… |
10 mg |
30925-10 |
More Info
|
Dofequidar |
A quinoline derivative and inhibitor of multidrug resistance; inhibits P-g… |
5 mg |
30925-5 |
More Info
|
Dofetilide |
An antiarrythmic agent that inhibits potassium channels; an inhibitor of t… |
10 mg |
15045-10 |
More Info
|
Dofetilide |
An antiarrythmic agent that inhibits potassium channels; an inhibitor of t… |
25 mg |
15045-25 |
More Info
|
Dofetilide |
An antiarrythmic agent that inhibits potassium channels; an inhibitor of t… |
5 mg |
15045-5 |
More Info
|
Dofetilide |
An antiarrythmic agent that inhibits potassium channels; an inhibitor of t… |
50 mg |
15045-50 |
More Info
|
Dofetilide-d4 |
An internal standard for the quantification of dofetilide by GC- or LC-MS |
1 mg |
26451-1 |
More Info
|
Dofetilide-d4 |
An internal standard for the quantification of dofetilide by GC- or LC-MS |
500 µg |
26451-500 |
More Info
|
Dofetilide N-oxide |
A metabolite of dofetilide; a less potent antiarrhythmic agent than dofeti… |
1 mg |
36294-1 |
More Info
|
Dofetilide N-oxide |
A metabolite of dofetilide; a less potent antiarrhythmic agent than dofeti… |
10 mg |
36294-10 |
More Info
|
Dofetilide N-oxide |
A metabolite of dofetilide; a less potent antiarrhythmic agent than dofeti… |
25 mg |
36294-25 |
More Info
|
Dofetilide N-oxide |
A metabolite of dofetilide; a less potent antiarrhythmic agent than dofeti… |
5 mg |
36294-5 |
More Info
|
Dog Farnesoid X Receptor Reporter Assay System |
Dog FXR Reporter Cells are prepared using INDIGO's proprietary CryoMite&tr… |
3x32 Well |
33507-332 |
More Info
|
Dog Farnesoid X Receptor Reporter Assay System |
Dog FXR Reporter Cells are prepared using INDIGO's proprietary CryoMite&tr… |
96 Well |
33507-96 |
More Info
|
DOG-IM4 |
An ionizable cationic lipid (apparent pKa = 5.6); immunization with LNPs c… |
1 mg |
37441-1 |
More Info
|
DOG-IM4 |
An ionizable cationic lipid (apparent pKa = 5.6); immunization with LNPs c… |
10 mg |
37441-10 |
More Info
|
DOG-IM4 |
An ionizable cationic lipid (apparent pKa = 5.6); immunization with LNPs c… |
5 mg |
37441-5 |
More Info
|
Dog Liver X Receptor, Alpha Reporter Assay System |
INDIGO Bioscience's assays are all-inclusive cell-based assay systems. In… |
96 well |
41032-96 |
More Info
|